MetaCap

Opus Genetics Statistics

NASDAQ: IRDHealth CareBiotechnology: Pharmaceutical PreparationsUSD

3.99-0.09 (-2.21%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Opus Genetics by the numbers

Opus Genetics has a market capitalization of $385.7 million based on 96.65M shares outstanding. With trailing EPS of $-1.48, Opus Genetics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.3% below its 50-day average and 7.3% below its 200-day average.

Average daily trading volume is 2.56M shares, or about $10.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IRD valuation vs. peer median

IRD compared with the median of 8 peer companies
MetricIRDPeer medianDifference
Market cap$385.65M$384.85M+0%
Avg. volume2.56M1.44M+77%

Peer median across 8 companies: AVTX, PHAT, OCS, PBYI, ASPE, PEPG, OVID, CRMD.

Valuation

Market cap
$385.65M
Price / sales (latest FY)
27.17
EPS (TTM)
$-1.48

Price and trading

Previous close
4.08
Open
4.01
Day range
3.89 – 4.05
52-week range
1.88 – 7.07
52-week change
+108.90%
Beta
—
Volume
1.19M

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
385.65M
Forward Pe
-5.29
Eps
-1.48
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
7.07
Week52 Low
1.88
Avg Volume
2.56M
Shares Outstanding
96.65M
Ma50
4.35
Ma200
4.30
Earnings Date
Nov 10, 2026
Pct From52w High
-43.56%
Pct From52w Low
112.23%

Related